Abstract | PURPOSE: PATIENTS AND METHODS: 20 patients of the " Glaucoma Center" of the Hospital "Umberto I" (Rome) were examined. These patients had POAG and used prostaglandin analogues (PA). Mean age was 75.5 years old (range 68-83); they had been suffering from PAOG since 10 years and were not affected by other relevant systemic diseases. One to three BTI were made into the lower orbicularis muscle using a 0.3 G needle (0.025 to 0.05 units for each injection site). RESULTS: The results were particularly significant in 18 out of 20 patients. Two patients showed slight improvements. A rating scale ranging from 0 to 6 points (0 corresponded to 'no effect' and 6 to the 'complete' resolution of the entropion) was used to evaluate the goals of the treatment. The average rating was 5.37 points. CONCLUSIONS:
|
Authors | A Librando, V Russo, M Tarallo, F Cruciani, S C Carlesimo, M Nebbioso |
Journal | European review for medical and pharmacological sciences
(Eur Rev Med Pharmacol Sci)
Vol. 17
Issue 13
Pg. 1835-8
(Jul 2013)
ISSN: 1128-3602 [Print] Italy |
PMID | 23852913
(Publication Type: Journal Article)
|
Chemical References |
- Prostaglandin Antagonists
- Botulinum Toxins
|
Topics |
- Aged
- Aged, 80 and over
- Botulinum Toxins
(therapeutic use)
- Entropion
(chemically induced, drug therapy)
- Eyelids
(physiology)
- Female
- Glaucoma, Open-Angle
(complications, drug therapy)
- Humans
- Iatrogenic Disease
- Male
- Oculomotor Muscles
(drug effects)
- Pilot Projects
- Prostaglandin Antagonists
(adverse effects, therapeutic use)
|